Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct 23;29(16):2093-7.
doi: 10.1097/QAD.0000000000000816.

No evidence of posttreatment control after early initiation of antiretroviral therapy

Sara Gianella  1 , Christy M Anderson, Douglas D Richman, Davey M Smith, Susan J Little
Affiliations

No evidence of posttreatment control after early initiation of antiretroviral therapy

Sara Gianella et al. AIDS. .

Abstract

As part of a retrospective analysis of 616 individuals followed from incident HIV infection for up to 18 years as part of the San Diego Primary Infection Cohort, we found 16 individuals who started antiretroviral therapy (ART) within the first 4 months of infection and subsequently interrupted ART after being virologically suppressed for a median of 1.75 years. No individual maintained sustained virologic control after interruption of ART, even when treatment was started during the earliest stages of HIV infection. Median time to HIV-RNA rebound after ART interruption was 0.9 months (range: 0.2-6.4 months).

PubMed Disclaimer

Figures

Figure 1
Figure 1
Panel A summarizes ART history (initiation to interruption) for each individual participant; Panel B shows individual times to HIV RNA rebound.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Palella FJ, Jr., Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43(1):27–34. - PubMed
    1. Wong JK, Hezareh M, Gunthard HF, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997;278(5341):1291–5. - PubMed
    1. Hoen B, Fournier I, Lacabaratz C, et al. Structured treatment interruptions in primary HIV-1 infection: the ANRS 100 PRIMSTOP trial. J Acquir Immune Defic Syndr. 2005;40(3):307–16. - PubMed
    1. Strain MC, Little SJ, Daar ES, et al. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis. 2005;191(9):1410–8. - PubMed
    1. Schmid A, Gianella S, von Wyl V, et al. Profound Depletion of HIV-1 Transcriptionally Active PBMC by Early cART during Primary HIV-1 Infection but Not by Treatment during Chronic Infection: Results of the Zurich Primary HIV Infection Study. PLoS One. 2010;5(10):e13310. - PMC - PubMed

Publication types

Substances